--- title: "BioAtla (BCAB.US) — Financial Reports" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/BCAB.US/norm.md" symbol: "BCAB.US" name: "BioAtla" parent: "https://longbridge.com/en/quote/BCAB.US.md" datetime: "2026-05-22T02:23:30.986Z" locales: - [en](https://longbridge.com/en/quote/BCAB.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/BCAB.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/BCAB.US/norm.md) --- # BioAtla (BCAB.US) — Financial Reports ## Income Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | EPS | -4.22 | -8.18 | -13.43 | -15.99 | -13.16 | | ROE | 69.05% | 116.09% | 263.07% | 924.11% | -828.19% | | Revenue | - | 2.00M | - | - | - | | Net income | -6.34M | -9.78M | -15.78M | -18.71M | -15.33M | | Operating income | -9.31M | -9.26M | -13.79M | -18.65M | -17.61M | | Gross margin | - | -299.75% | - | - | - | | Net margin | - | -489.20% | - | - | - | | Profit quality | - | - | - | - | - | ## Balance Sheet (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | A&L | 8.57M | 13.83M | 15.91M | 27.13M | 38.29M | | Leverage | -0.2296 | -0.3821 | -0.5093 | -1.62 | 70.00 | | BVPS | -22.48 | -28.51 | -26.57 | -14.26 | 0.4683 | | Turnover | 0.0854 | 0.0604 | 0.0000 | 0.2297 | 0.1726 | | Cash & STI | 1.96M | 7.12M | 8.32M | 18.21M | 32.36M | | Inv & Rec | - | - | - | - | - | | LT assets | 5.31M | 5.65M | 6.08M | 6.35M | 753000.00 | | Net debt | 4.13M | -918000.00 | -2.14M | -12.16M | -31.81M | ## Cash Flow Statement (USD) | Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | Operating CF | -5.27M | -7.92M | -9.88M | -14.12M | -16.29M | | Investing CF | - | - | - | - | - | | Financing CF | 110000.00 | 6.71M | -6000.00 | -36000.00 | -395000.00 | | Free CF | -7.30M | -506375.00 | -5.20M | -7.05M | -10.42M | | OCF coverage | - | - | - | - | - | | Repaid & issued | - | 7.13M | - | - | - | | CapEx | - | - | - | - | - |